Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer.

Starmans MH, Chu KC, Haider S, Nguyen F, Seigneuric R, Magagnin MG, Koritzinsky M, Kasprzyk A, Boutros PC, Wouters BG, Lambin P.

Radiother Oncol. 2012 Mar;102(3):436-43. doi: 10.1016/j.radonc.2012.02.002. Epub 2012 Feb 20.

PMID:
22356756
[PubMed - indexed for MEDLINE]
Free Article
2.

Impact of supervised gene signatures of early hypoxia on patient survival.

Seigneuric R, Starmans MH, Fung G, Krishnapuram B, Nuyten DS, van Erk A, Magagnin MG, Rouschop KM, Krishnan S, Rao RB, Evelo CT, Begg AC, Wouters BG, Lambin P.

Radiother Oncol. 2007 Jun;83(3):374-82. Epub 2007 May 25.

PMID:
17532074
[PubMed - indexed for MEDLINE]
3.

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

Breast Cancer Res. 2008;10(4):R65. doi: 10.1186/bcr2124. Epub 2008 Jul 28.

PMID:
18662380
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.

Buffa FM, Harris AL, West CM, Miller CJ.

Br J Cancer. 2010 Jan 19;102(2):428-35. doi: 10.1038/sj.bjc.6605450. Erratum in: Br J Cancer. 2010 Sep 7;103(6):929.

PMID:
20087356
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.

Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, Kok M, Teschendorff AE, Mook S, van 't Veer L, Caldas C, Salmon RJ, van de Vijver MJ, Wessels LF.

Breast Cancer Res. 2008;10(6):R93. doi: 10.1186/bcr2192. Epub 2008 Nov 13.

PMID:
19014521
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Semaphorin-plexin signalling genes associated with human breast tumourigenesis.

Gabrovska PN, Smith RA, Tiang T, Weinstein SR, Haupt LM, Griffiths LR.

Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.

PMID:
21925246
[PubMed - indexed for MEDLINE]
7.

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer.

Yu JX, Sieuwerts AM, Zhang Y, Martens JW, Smid M, Klijn JG, Wang Y, Foekens JA.

BMC Cancer. 2007 Sep 25;7:182.

PMID:
17894856
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

Zentralbl Gynakol. 2006 Apr;128(2):76-81.

PMID:
16673249
[PubMed - indexed for MEDLINE]
9.

Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures.

Chen J, Sam L, Huang Y, Lee Y, Li J, Liu Y, Xing HR, Lussier YA.

J Biomed Inform. 2010 Jun;43(3):385-96. doi: 10.1016/j.jbi.2010.03.009. Epub 2010 Mar 27.

PMID:
20350617
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.

Nuyten DS, Hastie T, Chi JT, Chang HY, van de Vijver MJ.

Eur J Cancer. 2008 Oct;44(15):2319-29. doi: 10.1016/j.ejca.2008.07.015. Epub 2008 Aug 18.

PMID:
18715778
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A gene expression signature identifies two prognostic subgroups of basal breast cancer.

Sabatier R, Finetti P, Cervera N, Lambaudie E, Esterni B, Mamessier E, Tallet A, Chabannon C, Extra JM, Jacquemier J, Viens P, Birnbaum D, Bertucci F.

Breast Cancer Res Treat. 2011 Apr;126(2):407-20. doi: 10.1007/s10549-010-0897-9. Epub 2010 May 21.

PMID:
20490655
[PubMed - indexed for MEDLINE]
12.

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2008 Apr 2;299(13):1574-87. doi: 10.1001/jama.299.13.1574. Retraction in: Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A. JAMA. 2012 Feb 1;307(5):453.

PMID:
18387932
[PubMed - indexed for MEDLINE]
13.

Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets.

Yao J, Zhao Q, Yuan Y, Zhang L, Liu X, Yung WK, Weinstein JN.

PLoS One. 2012;7(9):e45894. doi: 10.1371/journal.pone.0045894. Epub 2012 Sep 21.

PMID:
23029298
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.

Yau C, Benz CC.

Breast Cancer Res. 2008;10(4):R61. doi: 10.1186/bcr2120. Epub 2008 Jul 17.

PMID:
18631401
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.

Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, Orrico AR, Dreher D, Walters R, Parker J, Hu Z, He X, Palazzo JP, Olopade OI, Szabo A, Perou CM, Bernard PS.

Breast Cancer Res. 2006;8(2):R23. Epub 2006 Apr 20.

PMID:
16626501
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.

PMID:
14871811
[PubMed - indexed for MEDLINE]
Free Article
17.

Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer.

Nagelkerke A, Mujcic H, Bussink J, Wouters BG, van Laarhoven HW, Sweep FC, Span PN.

Cancer. 2011 Aug 15;117(16):3670-81. doi: 10.1002/cncr.25938. Epub 2011 Feb 11.

PMID:
21319150
[PubMed - indexed for MEDLINE]
Free Article
18.

Cell-type-specific responses to chemotherapeutics in breast cancer.

Troester MA, Hoadley KA, Sørlie T, Herbert BS, Børresen-Dale AL, Lønning PE, Shay JW, Kaufmann WK, Perou CM.

Cancer Res. 2004 Jun 15;64(12):4218-26.

PMID:
15205334
[PubMed - indexed for MEDLINE]
Free Article
19.

Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer.

Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA.

Clin Cancer Res. 2008 May 15;14(10):2944-52. doi: 10.1158/1078-0432.CCR-07-4397.

PMID:
18483361
[PubMed - indexed for MEDLINE]
Free Article
20.

Gene expression patterns in hypoxic and post-hypoxic adult rat retina with special reference to the NMDA receptor and its interactome.

Crosson LA, Kroes RA, Moskal JR, Linsenmeier RA.

Mol Vis. 2009;15:296-311. Epub 2009 Feb 9.

PMID:
19204789
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk